These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7012443)

  • 1. Assessment of Dharmendra antigen. (IV) Antigenic analysis of lepromins.
    Sinha S; Sengupta U; Ramu G; Desikan KV
    Lepr India; 1981 Jan; 53(1):6-10. PubMed ID: 7012443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Dharmendra antigen. (V) attempts for purification of specific skin delayed hypersensitivity (DH) inducing antigen (S) from lepromin.
    Sengupta U; Sinha S; Ramu G; Mukherjee A; Desikan KV
    Lepr India; 1982 Apr; 54(2):208-13. PubMed ID: 7132291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional electrophoretic analysis of humoral responses to culture filtrate of Mycobacterium bovis BCG in patients with leprosy and tuberculosis.
    Naito M; Izumi S; Yamada T
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):208-13. PubMed ID: 9728453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The granulomatous response of leprosy patients to lepromin and killed BCG.
    Han SH; Kuo SL; Hu SC; Lu ST
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):121-7. PubMed ID: 7004801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the reaction to Dharmendra antigen in the normal skin and in the lesion of leprosy patients.
    Price J; Davis M; Ramu G
    Lepr India; 1979 Jan; 51(1):87-95. PubMed ID: 449290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Dharmendra antigen. II. Standardisation of the antigens.
    Sengupta U; Ramu G; Desikan KV
    Lepr India; 1979 Jul; 51(3):316-22. PubMed ID: 513648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lepromin conversion in repeatedly lepromin negative BL/LL patients after immunization with autoclaved Mycobacterium w.
    Chaudhuri S; Fotedar A; Talwar GP
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):159-68. PubMed ID: 6684642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of two-dimensional immunoelectrophoresis for the characterization of antigens of BCG substrains.
    Lipińska R; Rzucidło L
    Acta Microbiol Pol; 1978; 27(1):35-40. PubMed ID: 76422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Dharmendra antigen. III. Comparative study with Mitsuda antigen.
    Sinha S; Sengupta U; Ramu G; Desikan KV
    Lepr India; 1979 Jul; 51(3):323-9. PubMed ID: 513649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serology of tuberculosis. III. Crossed immunoelectrophoretic analysis of sera from tuberculosis and leprosy patients with antigens from BCG.
    Jagannath C; Sengupta DN; Kasinathan S
    Tubercle; 1985 Dec; 66(4):277-87. PubMed ID: 3909564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
    Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
    Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Longitudinal study of a population of leprosy patients by the TML (leukocyte migration test)].
    Constant-Desportes M; Puissant A; Saurat JH
    Acta Leprol; 1983; 1(4):211-21. PubMed ID: 6377797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy.
    Singh PK; Ratna ; Jain PK; Mital VP
    Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous responses to antigens and irritants in patients of leprosy.
    Kumar B; Kaur S; Ganguly NK; Sharma S
    Lepr India; 1980 Jul; 52(3):405-10. PubMed ID: 7206636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of diluted Dharmendra lepromin.
    Kumar B; Kaur S; Ganguly NK
    Lepr India; 1980 Oct; 52(4):482-90. PubMed ID: 7464054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature and familial character of lepromin sensitivity in 27 families and their siblings.
    Kundu SK; Ghosh S; Hazra SK; Chaudhury S
    Lepr India; 1979 Oct; 51(4):465-74. PubMed ID: 522440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of lepromin positivity and immunoprophylaxis in household contacts of multibacillary leprosy patients: a pilot study with a candidate vaccine, Mycobacterium w.
    Sharma P; Kar HK; Kaur H; Misra RS; Mukherjee A; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):136-42. PubMed ID: 11036493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of standard Dharmendra lepromin.
    Sengupta U; Ramu G; Revankar CR; Ganapati R; Garg BR; Ghosh M; Desikan KV
    Indian J Lepr; 1984; 56(4):748-53. PubMed ID: 6549451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.